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Abstract The primary structure of a phospholipase A2, with
unique structural and functional characteristics, was determined.
The large subunit has 108 amino acid residues, linked by a
disulfide bridge to the small subunit, which contains 17 residues.
Its gene was cloned from a cDNA library. The nucleotide
sequence showed that the same RNA messenger encodes both
subunits, separated only by a pentapeptide, that is processed
during maturation.
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1. Introduction
Phospholipase A2 (PLA2) cleaves the ester bond at position
2 of the glycerol moiety of phospholipids, and is widely dis-
tributed in mammals, reptiles and arthropods [1]. Recently,
the old classi¢cation of PLA2 into three groups [2] was ex-
panded according to some structural and functional features,
such as the number of disul¢de bridges and the kind of amino
acids responsible for the catalytic activity, found in the newly
discovered PLA2 [3]. Dennis [3] reports seven well-de¢ned
PLA2 groups (I^VII) and adds three additional ones (VIII^
IX), not fully characterized. Apart from the general hydrolytic
function of these enzymes, several speci¢c biological functions
have been associated with members of the PLA2 superfamily.
Among these functions are anti-in£ammatory action [4], myo-
necrotic and muscle damaging e¡ects [5] and ion channel
blocking activity [6]. L-Bungarotoxin and crotoxin are two
other well known toxic venom components with PLA2 activ-
ity [7,8]. In the venom of the scorpion Pandinus imperator an
interesting heterodimeric phospholipase (IpTxi) was recently
described. This protein causes inhibition of ryanodine binding
to the Ca2 channels present in skeletal muscle, very likely
due to an indirect e¡ect caused by the fatty acid liberated by
the PLA2 activity of IpTxi [6].
In this communication we report the isolation and charac-
terization of a novel heterodimeric protein from the venom of
the same African scorpion P. imperator. The large subunit
shares sequence similarities with the phospholipase moiety
of IpTxi [6] and with those of phospholipases from honeybee
and Heloderma lizard, but has very little or no e¡ect on the
inhibition of ryanodine binding to Ca2 channels. The small
subunit is unique to this heterodimeric phospholipase. We
propose to call it phospholipin, and assume that together
with IpTxi it will constitute a new group of PLA2, number
X, following the classi¢cation proposed by Dennis [2].
2. Materials and methods
2.1. Chemicals and puri¢cation procedure
All chemicals were analytical grade reagents, obtained from sources
already described [6]. The venom of the scorpion was obtained in the
laboratory by electrical stimulation, dissolved in double-distilled
water, centrifuged at 15 000Ug for 15 min and the supernatant
lyophilized. The soluble venom applied to a Sephadex G-50 column
(0.9U190 cm) in 20 mM ammonium acetate bu¡er, pH 4.7, resolved
at least ¢ve fractions, of which number II contains phospholipase
activity; this fraction was further separated into a carboxymethyl-
cellulose (CM-cellulose) column, as described earlier for IpTxi [6].
One of the sub-fractions from CM-cellulose (number 3) contains
phospholipin, which was ¢nally obtained in homogeneous form by
high performance liquid chromatography (HPLC), using a C18 re-
verse-phase column (Vydac, Hisperia, CA).
2.2. Phospholipase assay and determination of speci¢city
The egg yolk-agarose system of Habermann and Hardt [9] was used
to follow the presence of phospholipase activity during the puri¢ca-
tion procedure. The enzyme speci¢city was determined using radio-
actively labeled substrates, and thin layer chromatography, as de-
scribed previously [10].
2.3. Amino acid analysis and microsequencing
Amino acid analysis was performed in samples hydrolyzed in 6 N
HCl with 0.5% phenol at 110‡C in evacuated, sealed tubes as de-
scribed [6]. Reduced and alkylated phospholipin, in amounts of
100 Wg each time, was cleaved independently by three di¡erent en-
zymes, and the corresponding peptides were separated by HPLC, us-
ing the conditions described in the legend for Fig. 1. Digestion with
Staphylococcus aureus protease V8 was performed in 100 mM ammo-
nium bicarbonate bu¡er, pH 7.8, for 4 h, at 40‡C, whereas hydrolysis
with endopeptidases AspN and ArgC was performed in the conditions
described elsewhere [11]. Microsequence determination was performed
on a 6400/6600 Milligen/Biosearch Prosequencer, using the peptide
adsorbed protocol on CD Immobilon membranes [11].
2.4. Mass spectrometry determination
The molecular weight of pure phospholipin was determined by mass
spectrometry, using a Kratos Kompact MALDI 3 v. 3.0.2 apparatus.
2.5. Cloning and sequencing
Two degenerated oligonucleotides encoding two di¡erent regions of
phospholipin were synthesized, as previously described [6].
Oligo 1 (ATG TGG GAR TGY ACN AAR TGG TG-, where N is
any nucleotide, R is A or G and Y is C or T-) corresponds to the
DNA sequence of amino acids 2^10 of the large subunit, whereas
oligo 2 (TGY GAR AAY GGN GTN GCN AC-) corresponds to
the DNA sequence of amino acids 4^11 of the small subunit.
Total RNA was puri¢ed as reported [6]. Messenger RNA was pu-
ri¢ed following the instructions of the Hybond mAP protocol (mes-
senger a⁄nity paper; Amersham, RPN.1511). Synthesis of cDNA and
the cloning of the cDNA library was performed as described [6,11].
The screening of the library was performed separately with oligonu-
cleotides 1 and 2. The clone detected with oligonucleotide 1 was an-
alyzed ¢rst. Inserts of cDNA from positive clones were ampli¢ed by
polymerase chain reaction (PCR) using V gt11 forward and reverse
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primers. PCR products were subcloned into pBluescript (pKS) phag-
emid. Clones of interest were sequenced using the Sequenase kit v. 2.0.
(U.S. Biochemical Corp.). Oligos M13-20 and M13 reverse were used
for sequencing [11].
3. Results and discussion
Fig. 1 shows the separation of soluble venom from P. im-
perator, by Sephadex G-50, CM-cellulose and HPLC. Fraction
II (Fig. 1A) contains phospholipase activity. Sub-fraction 1 in
Fig. 1B corresponds to IpTxi, capable of inhibiting ryanodine
binding to skeletal muscle Ca2 channels, as described by
Zamudio et al. [6], whereas sub-fraction 3 (Fig. 1B) also con-
tains a protein with phospholipase activity, which can be fur-
ther puri¢ed by HPLC (inset Fig. 1B). The major component
from the HPLC chromatogram (shown by the asterisk in the
inset of Fig. 1) was assumed to be homogeneous, based on
results obtained from SDS-gel electrophoresis (data not
shown). It contains phospholipase activity but very little, if
any, action on the inhibition of ryanodine binding to its re-
ceptor, contrary to IpTxi (data not shown). For this reason it
was called phospholipin, without any additional reference to
the ryanodine-sensitive Ca2 channels. Mass spectrometry
analysis showed that phospholipin was homogeneous, with a
molecular mass of 14 841.2. Based on this analysis, the mole-
cule was expected to contain in the order of 125 amino acid
residues. When this protein was loaded into the microse-
quencer, two amino acid residues of about the same amount
showed in each cycle, suggesting that it consisted of a hetero-
dimeric protein. Reduction and alkylation of phospholipin
permitted separation of the two subunits. This was obtained
by gel ¢ltration on a Bio-gel P-30 column, using the same
system described for IpTxi [6]. Each one of the subunits was
separately sequenced. Fig. 2A shows the results obtained. The
short subunit was directly sequenced to the end, and contains
only 17 amino acid residues, in which position 4 is occupied
by a cysteine, responsible for the covalent attachment of the
short peptide to the long one, through a disul¢de bond. The
larger subunit is composed of 108 amino acid residues and its
complete sequence was determined after enzymatic cleavage.
The sub-peptides were separated by HPLC (data not shown)
and the overlapping sequences obtained are shown in Fig. 2A,
underlining the overall amino acid sequence. Direct sequenc-
ing permitted the identi¢cation of the ¢rst 22 amino acid
residues, whereas four sub-peptides obtained by cleaving
with S. aureus protease V8 gave segments from amino acid
residues in positions 20^37, 65^71, 73^88 and 101^108. The
protease V8 cleavage was partial, since some of these frag-
ments still contained internally situated glutamic acid resi-
dues, supposed to be cleaved by this enzyme, when the hy-
drolysis goes to completion. Additional positioning of
residues was obtained by the use of two other proteinases.
They correspond to the segment at positions 38^59 obtained
by means of AspN protease hydrolysis, and sub-peptides 47^
64 and 89^101, obtained by ArgC protease cleavage. It is
worth mentioning that the speci¢city of ArgC was not 100%
either; the batch of enzyme we used was able to cleave a
lysine residue in position 46. The overall sequence determined
by direct Edman degradation of the sub-peptides of phospho-
lipin was additionally con¢rmed by the nucleotide sequence
obtained from the cloned gene. The obtained cDNA nucleo-
tide sequence of phospholipin is shown in Fig. 2B. The ¢rst
gene cloned was performed using oligo 1 (see Section 2), de-
signed to recognize the large subunit sequence, and the second
was oligo 2. When the ¢rst cloned gene, based on the amino
acid sequence of the large subunit (cloned with the help of
oligo 1), was hybridized with oligo 2, speci¢c for the short
peptide, it was shown that both oligos were capable of recog-
nizing the same clone. Under DNA sequencing analysis this
initially misleading result was immediately understood. The
gene that encodes both peptides is transcribed into the same
mRNA, which encodes the large and the small subunit as
well, separated by a pentapeptide Lys-Arg-Ser-Gly-Arg, which
is processed during maturation, in quite the same way as
initially demonstrated for the case of IpTxi, by our group
[6]. The analysis and interpretation of Fig. 2B is still not
complete, because there is a long 5P non-translated segment
of the cloned gene, whose function is still not certain. How-
Fig. 1. Puri¢cation of phospholipin. A: Soluble venom from P. im-
perator (120 mg of protein) was applied to a Sephadex G-50 column
(0.9U190 cm) equilibrated and run with 20 mM ammonium acetate
bu¡er, pH 4.7. Fractions of 5 ml each were collected and tested for
their phospholipase activity. B: Tubes corresponding to fraction II
were enzymatically active and were further applied to a CM-cellu-
lose chromatographic column (0.9U30 cm) dissolved in the same
bu¡er. The column was eluted with a linear gradient of sodium
chloride, as indicated. Fractions 1 and 3 displayed phospholipase
activity; the ¢rst contained IpTxi [6], whereas number 3 was ¢nally
separated by HPLC in a C18 reverse-phase column, as shown in the
inset. Phospholipin corresponds to the major, last sub-fraction, la-
beled with an asterisk. A linear gradient was used from solvent A
(0.12% tri£uoroacetic acid in water) to 60% B (0.10% tri£uoroacetic
acid in acetonitrile). Phospholipin corresponds to approximately
2.4% of the soluble venom. The experiments aimed at determining
its speci¢city, using radiolabeled phospholipids, clearly showed that
phospholipin has phospholipase A2 type activity (results not
shown).
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ever, the sequence that encodes the heterodimer phospholipin
molecule is very clear. It is composed of 393 nucleotides (in-
cluding the stop codon), starting at residue 1 with Phe (see
line 8 in Fig. 2B) labeled on the right hand side with number
+5 (which corresponds to glutamic acid), and ends at residue
130, just before the stop codon. In this sequence there is a
pentapeptide (double underlined) that is processed during ma-
turation, because it was not seen when we sequenced the het-
erodimeric peptides. There is a putative signal peptide (single
underlined in positions 315 to 0), but there are still 304 nu-
cleotides to the left side, with unknown function. That is, the
long 5P non-translated sequence (lower case letters) could con-
tain information for a longer signal peptide, that might start
at the ATG codon situated 9 residues to the left of the ¢rst
Met residue (our amino acid 315 in Fig. 2B) implying that
the signal peptide could start at amino acid 324. It is also not
clear if the putative signal peptide we have labeled is, in fact,
the signal peptide. We are concerned about the presence of
two Arg residues within this segment. Thus, the possibility
that this segment corresponds to the message for translating
an unknown third peptide or long propeptide needs further
analysis and work. Also, the long 3P non-translated region
(104 nucleotides), before the putative polyadenylation site
(bold capital letters at the end of the ¢gure) needs some addi-
tional work.
Although the primary structure of the large subunit of
phospholipin presents a close similarity with PLA2 from hon-
ey bee and Heloderma lizard, which would place it in the
group III phospholipases, it is not certain that it ¢ts there.
One of the main reasons is because it is a heterodimer in
which the small subunit (17 amino acid residues) has no re-
semblance to any other protein known. It seems clear that the
large subunit moiety is the one bearing the phospholipase
activity, in all three examples mentioned. Also L-bungarotox-
Fig. 2. Amino acid and nucleotide sequence of phospholipin. A: Primary structure of phospholipin as determined by direct sequencing of the
native peptides (underlined DS) and fragments produced by enzymatic hydrolysis with protease V8 (labeled V8), endopeptidase AspN (labeled
ASP-N) and endopeptidase ArgC (labeled ARG-C). B: Nucleotide sequence from the 5P to the 3P end of the clone that encodes phospholipin.
The sequence corresponding to the putative signal is underlined, the pentapeptide eliminated during processing is double underlined, bold letters
indicate the possible polyadenylation site, whereas lower case letters indicae the 5P and 3P non-coding regions of the gene. Numbers on the right
hand side correspond to the positions of nucleotides from the signal peptide to the stop codon (upper lines) and to their corresponding amino
acids (lower lines).
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in, a presynaptically active phospholipase isolated from the
snake Bungarus multicinctus [7], and IpTxi, isolated from the
scorpion P. imperator [6] are heterodimers, but again there is
no resemblance in structure or function, when we compare the
small subunits of these three venom components, as shown in
Fig. 3. Also functionally, the short peptide of L-bungarotoxin
with 61 amino acid residues was suggested to be a K channel
blocker [12], whereas that of IpTxi (27 amino acid residues)
apparently has no measurable function towards Ca2+ chan-
nels or towards any other of several ion channels assayed (see
[6]). Phospholipin has the shortest of all the small subunit
peptides of the three heterodimeric phospholipase known,
and we do not know either what its function is. The three-
dimensional structure of phospholipin was modelled using the
Swissmod program and facilities (data not shown), and the
results of the model suggests that cysteine at position 4 of this
17 amino acid peptide is bound to cysteine in position 101 of
the phospholipase moiety. Structurally, phospholipin shows
two additional cysteines (one more disul¢de bridge), not
present in IpTxi, which might be responsible for folding phos-
pholipin in a di¡erent manner than that of IpTxi. It can be
speculated that this structural di¡erence is responsible for a
distinct substrate speci¢city, hence a di¡erent biological ac-
tion, such as the indirect e¡ect on the binding of ryanodine
to the Ca2 channels, described for IpTxi. Due to these char-
acteristics, phospholipin described here, although similar to
group III phospholipases A2, seems to constitute the proto-
type of a novel group of PLA2, which would be number X,
according to the classi¢cation recently proposed by Dennis
[3].
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Fig. 3. Comparative analysis of the small phospholipase subunits. The amino acid sequence of the small subunits of phospholipin (this work),
and those of IpTxi [6] and L2-bungarotoxin [13] were compared, after alignment of the ¢rst cysteinyl residues by adding gaps (-) to the sequen-
ces of phospholipin and IpTxi. Very little identity exists. Phospholipin (a) and IpTxi (b) share ¢ve identical amino acid residues at the same po-
sition (18% identity), whereas with the small L1 subunit of bungarotoxin (c) only two positions were occupied by identical residues (less than
4% identity). Bold italics indicate identical residues in all three sequences, italics indicate identity for only two of the sequences on pairwise
comparison. Identical residues are highlighted by asterisks.
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